The rennin-angiotensin system (RAS) has been implicated in the development of diabetic vascular complications. Peptidyl-dipeptidase A (angiotensin converting enzyme, ACE) has a major role in this system. The aim of the present study was to clarify the effect of intraperitoneal administration of